These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8182944

  • 1. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
    Quesnel B, Preudhomme C, Vanrumbeke M, Vachee A, Lai JL, Fenaux P.
    Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Preudhomme C, Vachee A, Quesnel B, Wattel E, Cosson A, Fenaux P.
    Leukemia; 1993 Jul; 7(7):1071. PubMed ID: 8321023
    [No Abstract] [Full Text] [Related]

  • 7. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB, Mallo M, Arenillas L, Salido M, Espinet B, Pedro C, Florensa L, Serrano S, Solé F.
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY, Kim WS, Bang YJ, Jung CW, Park S, Yoon WJ, Cho KS, Kim IS, Jung TJ, Choi IY.
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T, Yasuyama M, Kawauchi K.
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M.
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C, Bacher U, Schnittger S, Alpermann T, Zenger M, Kern W, Haferlach T.
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison between immunogenotypic findings in de novo AML and AML post MDS.
    Ohyashiki JH, Ohyashiki K, Kawakubo K, Fujimura T, Shimamoto T, Nakazawa S, Kimura N, Toyama K.
    Leukemia; 1993 Nov; 7(11):1747-51. PubMed ID: 7694003
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.